Open Accessibility Menu

Coronavirus (COVID-19) Vaccine Update Click here to learn more.

For information about COVID-19 or to view additional resources, please click here.

Obstetrics & Gynecology

About Us

We are now offering online virtual health visits. Please contact us at (202) 741-2500 to schedule an appointment. Click here for more information.

The Department of Obstetrics and Gynecology at The GW Medical Faculty Associates provides comprehensive gynecologic and obstetric care to women of all ages in Washington, DC and the surrounding area. Our department offers a full range of quality care for women of all ages, with an emphasis on preventative health care and education.

Our services range from routine care such as gynecologic exams and routine pregnancy examinations to specialties that include treatment for various adolescent and menopausal conditions. As a part of a multi-specialty practice, our doctors are equipped to work with you in their own discipline and draw from the expertise of other specialties in order to provide a holistic approach to gynecological care.

Please note: all OB/GYN appointments are being moved to 22nd & I St., NW (5th Floor). Click here for our department resources and updates for our patients regarding Coronavirus (COVID-19)

Online Resources:

Conveniently Located

Clinical Trials

  • SLIPS Study
    This study is looking at the relationship between sleep and perinatal mood disorders such as depression and anxiety. Participants will wear a wrist monitor like a fit bit for 10 days to help researchers gain information into sleep patterns during pregnancy and postpartum and will answer questionnaires about their mood.
    Read More
  • Vaginal vs Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth
    Preterm birth is one of the leading causes of neonatal morbidity and mortality. One of the most significant risk factors is a history of a prior spontaneous preterm birth. Intramuscular progesterone is the only FDA approved medication for the prevention of recurrent preterm birth. Vaginal progesterone is not FDA approved for the prevention of recurrent preterm birth, but has been found to beneficial. Given the presence of trials demonstrating efficacy for both intramuscular and vaginal progesterone in the prevention of recurrent preterm birth, but limited information one being more superior to the other, we are performing a trial comparing vaginal progesterone and intramuscular progesterone for the prevention of recurrent spontaneous preterm birth in women with a history of prior spontaneous preterm birth.
    Read More
  • Sonography-Guided Transcervical Ablation of Uterine Fibroids (SONATA)
    [This study is no longer recruiting.] The SONATA Study is an FDA-approved clinical study designed to establish the safety and effectiveness of a new, investigational device to reduce heavy menstrual bleeding caused by uterine fibroids. The device, called the SONATA System, targets fibroids rather than treatment or removing the entire uterus. If effective, this device will provide an alternative to hysterectomy that is: incision-free, preserves the uterus, does not require general anesthesia and is an outpatient procedure.
    Read More
  • Randomized Controlled Trial: Physical Exam Indicated Cerclage in Twin Gestations
    Women with twin pregnancy who have a dilated (open) cervix detected on physical exam before 24 weeks are at increased risk for delivering their babies preterm (before 37 weeks gestation). Prematurity is associated with many complications for the babies including respiratory (breathing) problems, bleeding inside of the brain (a form of stroke), increased risk of infection, kidney, temperature and feeding problems. The primary objective of this study is to determine if physical exam indicated cerclage use reduces the incidence of spontaneous PTB in asymptomatic women with twin gestations with cervical dilation diagnosed on pelvic exam before 24 weeks of gestation.
    Read More
  • Prevention of Postpartum Hemorrhage: Pharmacokinetics and Pharmacodynamics of Tranexamic Acid
    Tranexamic acid was shown to significantly reduce risk of mortality when given to women with diagnosed postpartum hemorrhage in the recent Lancet WOMAN Trial.* The purpose of this study is to determine the optimal dose for using tranexamic acid to prevent postpartum hemorrhage during routine cesarean section. Women undergoing cesarean section will be eligible and must not have a history of blood clots or a known clotting condition. *http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31111-X/fulltext
    Read More
  • Placental Perfusion Imaging Using Arterial Spin Labeled MRI
    In this study, we are developing non-invasive tools to identify early signs of abnormalities of the placental function using arterial spin labeling (ASL) based on fetal MRI. ASL is a particularly attractive method for early and safe monitoring during pregnancy given that ASL is completely non-invasive and does not require contrast agents or exposure to ionizing radiation. Our specific aim is to develop and validate placental perfusion imaging with substantially improved image quality and sensitivity to abnormalities.
    Read More
  • Fetal Vasoreactivity in normal pregnancy
    This study is being performed at Children's National Health System. We are trying to understand how the normal fetus controls blood flow to the different parts of the body such as the lungs and brain. We will measure your baby's blood flow using the same ultrasound approach used by your obstetrician. We will test your baby's control of blood flow by measuring the responses to changes in your (the mom's), levels of oxygen and carbon dioxide. We will make these changes by asking you to breathe extra oxygen for short periods of time. If your obstetrician determines that your pregnancy is uncomplicated, you and your baby are eligible for this study.
    Read More
View All Clinical Trials